HFNC During Bronchoscopy for Respiratory Failure
Official title: Role of High Flow Nasal Cannula During Fiber-optic Bronchoscopy in Patients With Respiratory Failure
Run by Mansoura University · NCT07880964 · Data updated 2026-11-12
This study tests whether using high-flow nasal oxygen during fiber-optic bronchoscopy is safe and helpful for patients with respiratory failure.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Mansoura University Academic / other |
| Locations | 1 site (Al Mansurah, Dakahlia Governorate) |
| Status | Recruiting |
| Started | April 12, 2026 |
| Main results expected | October 2027 |
| Study ends | November 2027 |
| Registry record updated | October 19, 2026 |
| Trial ID | NCT07880964 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with respiratory failure who are undergoing clinically indicated fiber-optic bronchoscopy and consent to participate.
✕Probably not a fit
Patients with immediate intubation needs, severe hypoxemia despite maximal non-invasive support, hemodynamic instability, or contraindications to bronchoscopy or HFNC may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This prospective, single-group study evaluates the safety and potential benefits of high-flow nasal cannula (HFNC) oxygen during fiber-optic bronchoscopy in patients with respiratory failure. HFNC will be started about 10 minutes before the procedure and continued through the bronchoscopy and for 1–2 hours afterward, with oxygen flow adjusted to keep SpO2 near target ranges. The study will monitor oxygenation, ventilation, procedure interruptions, adverse events, patient comfort, and clinical outcomes to determine feasibility and potential improvements over standard care. Patients will receive HFNC via the Vapotherm Precision Flow Hi-VNI system, with FiO2 titrated to maintain SpO2 targets depending on whether they have type 2 respiratory failure. Standard monitoring, including arterial blood gases, will be used to assess safety and response during and after the procedure.
Why it matters
Potential benefit: If successful, HFNC during bronchoscopy could improve oxygenation and reduce complications for patients with respiratory failure undergoing the procedure.
How similar studies have gone: Previous studies in similar settings have explored HFNC during procedures with mixed but encouraging signals for safety and tolerability.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Participants will be eligible for inclusion if they meet all of the following criteria: 1. Adult patients undergoing clinically indicated fiber-optic bronchoscopy. 2. Patients with respiratory failure requiring supplemental oxygen or respiratory support. 3. Patients who provide written informed consent to participate in the study. Exclusion Criteria: * Participants will be excluded if they meet any of the following criteria: 1. Patients requiring immediate endotracheal intubation or invasive mechanical ventilation before bronchoscopy. 2. Patients with severe or refractory hypoxemia despite maximal non-invasive oxygen/respiratory support before the procedure. 3. Hemodynamic instability that precludes safe fiber-optic bronchoscopy. 4. Patients with contraindications to fiber-optic bronchoscopy or to the planned bronchoscopy procedure. 5. Patients who refuse or withdraw informed consent. 6. Patients in whom HFNC cannot be safely applied or tolerated.
Where it's running
-
Faculty of Medicine, Mansoura University
Al Mansurah, Dakahlia Governorate, Egypt Recruiting
Study contacts
- Study coordinator: Mohammed Shehta, associate professor-chest med.
- Email: dr_mshehta@mans.edu.eg
- Phone: +201004344106
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Respiratory progression in adults with Duchenne muscular dystrophy: a long-term observational study
This study tests how respiratory function changes over three years in adults with genetically confirmed Duchenne muscular dystrophy.
-
Epidural spinal cord stimulation to help breathing after cervical spinal cord injury
This trial tests whether adding epidural spinal cord stimulation to standard care can improve breathing in adults with cervical spinal cord injury and respiratory failure.
-
Brain blood flow and brain regulation in critically ill kids
This study tests how blood flow in the brain behaves in critically ill children using a noninvasive ultrasound (TCD) to see if brain autoregulation patterns relate to outcomes.
-
Ciprofol versus propofol for sedating adult ICU patients on noninvasive respiratory support
See if ciprofol works better than propofol for sedating adults in the ICU who are receiving noninvasive ventilation, high-flow nasal cannula, or oxygen therapy.
-
Using EEG to monitor sleep quality in ICU patients with respiratory failure
We will test whether continuous EEG monitoring can better track sleep quality than nurse observations in conscious adults hospitalized in the ICU for acute respiratory failure.
-
High-flow nasal oxygen combined with noninvasive ventilation for acute respiratory failure
This test will try alternating high-flow nasal oxygen and noninvasive ventilation to see if it helps adults with acute respiratory failure breathe better than noninvasive ventilation alone.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.